Cardiac Science competitors

Curt R. Hartman is the President and Chief Executive Officer of CONMED Corporation. He was appointed to the Board of Directors of CONMED on March 1, 2014, assumed the Interim CEO role on July 22, 2014, and became the full-time President and CEO on November 9, 2014. Prior to CONMED, he had a twenty-two-year career at Stryker Corporation (“Stryker”), a publicly-traded large-cap medical device company, from 1990 through February 2013. During his tenure with Stryker, he served as Interim Chief Executive Officer from February 2012 to October 2012 and as Vice President and Chief Financial Officer from April 2009 to October 2012. Mr. Hartman initially joined Stryker as a Manufacturing Engineer. He subsequently held roles of increasing responsibility to include Unit Supervisor, Production Unit Manager, Director of Information Technology, National Accounts Director and Vice President, General Manager, and Global President of the Instruments Division. Mr. Hartman has a Bachelor of Science degree in Aerospace Engineering from the University of Michigan and holds a Harvard AMP Program Certificate from Harvard Business School. He also has completed the Stryker Advanced Leadership Program at Harvard Business School. Mr. Hartman currently serves on the Board of Veran Medical Technologies, a venture-backed medical technology company.

A Strategic and Operational CFO with broad & deep geographic and business experience in Pharmaceutical, Biotech, Medical Device & Consumer Goods leading international markets worldwide in Financial operations, General Management, Information Technology, Procurement & Facilities. A strategic thinker partnering with leadership to develop long-range plans and deliver business & financial results through fact-based decision support, developing diverse cross-functional talent and implementing comprehensive metrics. Identify and sponsor change through P&L efficiencies, improved cash flow and new business models, fueling profit growth and margin expansion. Appling this approach to lead “beyond the numbers” with broad business acumen to impact the business.Recognized as a thought leader and business partner with a hands-on approach going beyond the financial leader role, a strong communicator who sorts through complexity and asks the right questions, willing to challenge the status quo & lead transformational change. Develop global finance organizations, placing leaders beyond the finance function.Experienced Management Board member of various sized healthcare, life science and consumer goods companies from start-up to multi-billion dollar global market leaders, driving high-growth businesses, improving turn-arounds and acquisition integration. Led financial organizations from 5 to 200 employees.Areas of expertise:Growth Strategies | Global Leadership | Board Member | Fact-Based Decision Support | Strategic & Financial Planning | Worldwide P&L Management | International Finance | Cost Accounting | Competitive Intelligence | Talent DevelopmentAdditional skills:Internal Financial Controls | Financial & Portfolio Analysis | Tax Planning | International Treasury Functions | Capital Structure & Cash Management | Mergers & Acquisition | Project Management | Investor Relations | New Product Launches | Acquisition Integration

Nacho Abia is a Mng Dir:Consumer Products at Olympus Europa Holding GmbH, Chairman at Olympus Espana, and Board Member at Olympus Imaging Corp. He has worked as Head:Americas Therapeutic Solutions at Olympus, President at Olympus Imaging Corp, and CEO/Managing Director at Olympus Espana. Nacho works or has worked as Mgr:South European Marketing at Sony Europe. He attended Universitat Politècnica de Catalunya - UPC and Barcelona Business Administration School.

Founder of The Chopra Foundation, a non-profit entity for research on well-being and humanitarianism, and Chopra Global, a whole health company at the intersection of science and spirituality, is a world-renowned pioneer in integrative medicine and personal transformation. Chopra is a Clinical Professor of Family Medicine and Public Health at the University of California, San Diego and serves as a senior scientist with Gallup Organization.